Thesis review: is it worth it?

What is Thesis and how does the personalization actually work?

Thesis (legally Take Thesis, sold at takethesis.com) is a direct-to-consumer supplement brand, not a telehealth or clinical service. There is no prescriber, no diagnosis, and no lab testing — it is an over-the-counter dietary supplement subscription with a personalization layer bolted on top.

The flow works like this:

1. You take an onboarding quiz. It asks about your goals (focus, energy, memory, mood, motivation), your sleep, caffeine tolerance, diet, and a few health questions.
2. Thesis recommends a "starter kit" of four blends drawn from its six formulas. The blends are not custom-compounded to you — they are fixed, off-the-shelf recipes, and the quiz simply matches you to four of the six.
3. You receive four small boxes, each with six single-serving sachets (24 doses total per month). The intent is that you try a different blend across a few days, rate how you feel, and converge on the one or two that work best for you.
4. You get access to a "coach" — a customer-experience representative, not a licensed clinician — who can help you adjust your selections for the next shipment.

It is important to be precise about what "personalized" means here. Thesis is not formulating a unique pill for your brain chemistry. It is doing structured trial-and-error with six pre-made products. That is a reasonable and honest model — individual response to nootropics genuinely does vary — but it is closer to "guided sampling" than to true personalization, and the marketing language oversells the science of the matching.

Each blend also comes in a caffeinated or caffeine-free version, which matters a great deal given how central caffeine is to the formulas (see below).

How do Thesis nootropics work?

"Nootropic" is a marketing umbrella, not a regulated drug class. Thesis blends combine several categories of compounds that act through different, mostly modest mechanisms:

• Stimulants — caffeine (and caffeine-like compounds theacrine, theobromine, dynamine) that block adenosine receptors to increase alertness.
• Cholinergics — Alpha-GPC and CDP-choline (citicoline), which supply choline for acetylcholine, a neurotransmitter involved in attention and memory.
• Adaptogens — ashwagandha and Sceletium tortuosum (Zembrin), used for stress and mood rather than raw cognition.
• Herbal/botanical cognitive agents — Bacopa monnieri, Ginkgo biloba, Lion's Mane, saffron, sage.
• Amino acids and precursors — L-theanine, N-acetyl-L-tyrosine, L-phenylalanine.

The honest mechanistic picture is that the *acute* feeling most users describe — sharper, more "on" within an hour — is overwhelmingly the caffeine + L-theanine acting, while the botanical and choline ingredients are slow-acting and only show effects (if any) over weeks of daily use. That distinction is the single most useful thing to understand before paying for Thesis.

What is in each Thesis blend, and what does the evidence say?

Thesis publishes full per-serving doses (no hidden proprietary blends), which is genuinely better than many competitors. Below are the published formulas (caffeinated versions) with an honest read of the evidence for the headline ingredients.

The shared base: caffeine + L-theanine

Every caffeinated blend contains 100 mg caffeine + 200 mg L-theanine. This is the most evidence-supported part of the entire lineup. Randomized trials show the caffeine–L-theanine combination improves specific attention and task-switching measures versus placebo, while smoothing some of caffeine's jitter (e.g., PMID 18681988; PMID 29420994). The catch: 100 mg caffeine is about one cup of coffee, and 200 mg L-theanine costs pennies. You can replicate this base for a few dollars a month.

Clarity

Lion's Mane 500 mg, Alpha-GPC (as AlphaGrain) 500 mg, Epicatechin 278 mg, 7,8-DHF 30 mg, plus the caffeine/L-theanine base.

• Lion's Mane (Hericium erinaceus): The most-cited human trial gave older adults with mild cognitive impairment 3 g/day for 16 weeks and saw improvement that faded after stopping (PMID 18844328). Note that trial used ~3 g of mushroom *powder* — Thesis provides 500 mg of extract, a different and lower exposure, so extrapolating that result to this dose is not justified.
• Alpha-GPC: A choline donor with some evidence in cognitive-decline populations; evidence in healthy adults is thin.
• 7,8-DHF and epicatechin: Mechanistically interesting (BDNF/TrkB signaling, flavanol blood flow) but human cognitive data are preliminary.

Logic

Phosphatidylserine 400 mg, Bacopa monnieri (Synapsa) 320 mg, Ginkgo biloba 160 mg, Omega-3 (50% DHA) 200 mg, Triacetyluridine 30 mg, Theobromine 100 mg, plus the base.

• Bacopa monnieri is the strongest botanical here. A meta-analysis of randomized controlled trials found Bacopa improved cognition — particularly speed of attention — but emphasized that effects emerge only with chronic dosing of about 12 weeks (PMID 24252493). The 320 mg dose of a standardized extract is reasonable and study-aligned.
• Phosphatidylserine has modest, mixed memory data, mostly in older adults.
• Ginkgo biloba: Large trials (e.g., the GEM study, JAMA 2008) found it did *not* prevent dementia or cognitive decline; everyday cognitive benefits in healthy people are weak at best.

Energy

Citicoline (CDP-choline) 300 mg, N-acetyl-L-tyrosine 300 mg, NAC 500 mg, Theacrine (Teacrine) 100 mg, Zynamite (mango leaf) 300 mg, Sabroxy 100 mg, plus the base.

• Citicoline has some supportive attention data at 250–500 mg.
• N-acetyl-L-tyrosine may help cognition under acute stress or sleep loss, less so when rested.
• Theacrine is a caffeine-like stimulant; stacked on the 100 mg caffeine base, the "energy" effect is largely stimulant-driven.

Motivation

L-phenylalanine 500 mg, Artichoke extract 450 mg, Forskolin 250 mg, Dynamine (methylliberine) 100 mg, B12 1000 mcg, plus the base.

This blend leans on the "CILTEP" concept (artichoke + forskolin to raise cAMP) plus a dopamine precursor and another stimulant (dynamine). The CILTEP mechanism is largely theoretical in humans; this is one of the more speculative formulas.

Creativity

Panax ginseng (GS15-4) 200 mg, Alpha-GPC 300 mg, Ashwagandha (KSM-66) 300 mg, Sceletium tortuosum (Zembrin) 25 mg, Agmatine sulfate 250 mg, plus the base.

Confidence

Ashwagandha (Shoden) 120 mg, Sage extract 333 mg, Saffron (Affron) 28 mg, Sceletium tortuosum (Zembrin) 25 mg, Magnesium bisglycinate, Magnolia bark (DHH-B) 10 mg, plus the base.

• Ashwagandha has reasonable evidence for *stress and anxiety* reduction (not cognition per se), but carries a real safety signal discussed below.
• Saffron (28 mg Affron): A meta-analysis of randomized trials found saffron significantly more effective than placebo for mild-to-moderate depressive symptoms and non-inferior to standard antidepressants in the trials studied (PMID 30036891). This is a genuine mood ingredient, and 28 mg is within the commonly studied dose range (about 28–30 mg/day).

Does Thesis actually work?

Here is the balanced answer. The acute, same-day effects most users report are real but are primarily the caffeine + L-theanine base — a combination with solid trial support but no proprietary advantage. The slow-building, blend-specific effects rest on individual ingredients whose evidence ranges from decent (Bacopa, saffron, ashwagandha for stress) to weak or mostly theoretical (forskolin/CILTEP, 7,8-DHF, agmatine in humans).

Several structural caveats matter for honesty:

• There are no clinical trials on Thesis blends themselves. Thesis cites studies on individual ingredients, not on its finished, multi-ingredient products. Whether a 7-ingredient blend behaves like the sum of its single-ingredient studies is unknown — and many doses here are below the amounts used in the cited research.
• Stacking many sub-threshold ingredients is a common supplement pitfall. Spreading the budget across six to eight compounds per blend can mean none reaches its studied dose.
• Strong placebo and expectancy effects are well documented for nootropics, and a personalization narrative ("we matched this to you") amplifies them.

This does not mean Thesis is useless — many people genuinely feel better focus, and the daily ritual plus caffeine timing can be real, useful behavior change. It means the *premium* over a basic caffeine/L-theanine + (optionally) Bacopa routine is buying convenience, sampling, and packaging more than a proven cognitive edge.

Are Thesis nootropics safe, and what are the side effects?

For most healthy adults, the ingredients are generally recognized as safe at these doses, but there are real considerations.

• Caffeine load. At 100 mg per dose, stacking blends or adding coffee can cause jitteriness, anxiety, palpitations, and insomnia — the most commonly reported complaints. Use the caffeine-free versions if you are sensitive or dose in the afternoon.
• GI effects. Headaches, nausea, heartburn, and digestive upset are frequently reported, often early on.
• Ashwagandha and the liver. This is the most important safety point. The NIH LiverTox database classifies ashwagandha as a likely cause of clinically apparent liver injury (likelihood score B), with reported cases of cholestatic/mixed hepatotoxicity typically appearing 2–12 weeks after starting (NIH LiverTox). Multiple case reports and a February 2024 Australian (TGA) regulatory safety advisory reinforce this. Ashwagandha may also affect thyroid hormone levels and is not advised in pregnancy or breastfeeding.
• Stimulant–herb interactions. People on stimulant medications, MAOIs/SSRIs, thyroid medication, blood thinners (Ginkgo affects bleeding risk), or with cardiac or blood-pressure conditions should not start these blends without talking to a clinician.
• Regulatory reality. Dietary supplements are not pre-approved by the FDA for safety or efficacy; the FDA acts only after products reach the market (FDA). Thesis states its products are made in cGMP-compliant facilities and third-party tested for purity, which is a meaningful quality signal but is not the same as FDA approval of the formulas.

Anyone pregnant, breastfeeding, under 18, or managing a chronic condition or psychiatric medication should treat Thesis as a "ask your doctor first" product, not a casual purchase.

How do you take Thesis, and how much does it cost?

You take one blend per day (3–4 capsules), ideally on the days and at the times you most need cognitive output, and you rotate blends to find your best fit during the trial month. Thesis recommends cycling and taking periodic breaks.

On price, Thesis is at the expensive end of the market:

• Subscription: ~$79/month for 24 doses (four blends × six doses).
• One-time purchase: ~$119/month for the same.
• A 30-day money-back guarantee is offered, which materially lowers the risk of the first order.

That works out to roughly $3.30 per dose on subscription, and you only receive six doses of each blend per month — not enough of any single formula to run the 8–12-week chronic course that the Bacopa and Lion's Mane research actually requires. To take one blend daily for a full month, your cost climbs well beyond the headline price.

How does Thesis compare to the alternatives?

• Versus single-ingredient supplements: If you want what's actually best-supported here, you can buy L-theanine + caffeine and a standardized Bacopa extract separately for a small fraction of Thesis's cost and at full studied doses. The trade-off is no sampling, no packaging, and no guidance.
• Versus fixed all-in-one nootropics (e.g., Mind Lab Pro, Performance Lab): Those offer one formula rather than six to sample. Thesis's advantage is the test-and-learn model; critics note Thesis includes excipients (magnesium stearate, microcrystalline cellulose) some cleaner competitors avoid.
• Versus just coffee: For many people, coffee plus adequate sleep and exercise delivers most of the acute alertness benefit at near-zero cost. This is the honest baseline any nootropic should be measured against.

The bottom line

Thesis is a well-packaged, transparent (fully dosed, no proprietary blends) nootropic subscription with a genuinely useful sampling model and a no-risk return window. Its strongest, most defensible ingredients are the caffeine + L-theanine base, Bacopa (in Logic), and saffron and ashwagandha for mood and stress (in Confidence/Creativity) — but many of its more exotic ingredients are under-dosed, mechanistically speculative in humans, or untested as part of a blend. There are no studies on the finished products themselves.

It is reasonable to try if you value the convenience of guided sampling, you tolerate stimulants, you are not pregnant or on interacting medications, and you have screened ashwagandha against your liver and thyroid health. It is hard to justify long-term at $79–$119/month when the best-evidenced components can be bought individually for far less and dosed properly. Treat Thesis as a one-month diagnostic to learn which ingredients help you — then consider replicating the winners more cheaply, rather than as a permanent subscription.

*This article is educational and not medical advice. Talk to a qualified clinician before starting any supplement, especially if you are pregnant or breastfeeding, under 18, take prescription medication, or have a liver, thyroid, cardiac, or psychiatric condition.*